Skip to main content

Not investment advice.Read full disclaimer

CARM: Carisma Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.19×avg

Market Cap

4185USD

P/E Ratio

0.0TTM

Div Yield

-ann

Continue with finqOS

Explore Carisma Therapeutics, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Carisma Therapeutics, Inc.

CARMOther OTC·USD·Closed

Carisma Therapeutics, Inc.

CARMOther OTC·USD·Closed

$0.00

+0.00%

$0.00

+$0.00 (0.00%)

52W Range

0thpctl

Volume

0.19×avg

Mkt Cap

4185USD

P/E

0.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings